WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its off-the-shelf Rep/Cap plasmid offering, designed to streamline ...
Viruses are capable of efficiently transferring and expressing their genomes in many mammalian cell types, making viral vectors attractive for delivering genes to treat a variety of genetic diseases.
Charles River’s off-the-shelf rep/cap plasmids are intended to simplify gene therapy supply chains. Charles River Laboratories International announced the launch of its off-the-shelf ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback